76
|
Pugnet G, Puéchal X, Fillatre P, Terrier B, Decaux O, Guillevin L. FRI0264 Cardiac Manifestations of Granulomatosis with Polyangiitis at Diagnostic. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
77
|
Regent A, Ly K, Groh M, Khifer C, Lofek S, Tamby M, Baud V, Labrousse F, Guillevin L, Brézin A, Le Jeunne C, Mouthon L. Implication du système de l’endothéline et intérêt potentiel du macitentan au cours de l’artérite à cellules géantes (maladie de Horton). Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.278] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
78
|
De Luna G, Chauveau D, Maurier F, Hatron P, Gobert P, Karras A, Aniort J, Marchand-Adam S, Carron P, Mania A, Guillevin L, Terrier B. Profil évolutif des patients traités par échanges plasmatiques au cours des vascularites systémiques nécrosantes. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
79
|
Guellec D, Cornec-Le Gall E, Groh M, Hachulla E, Karras A, Charles P, Dunogue B, Abad S, Devauchelle-Pensec V, Guillevin L, Saraux A, Cornec D. AB0560 ANCA-Associated Vasculitis in Patients with Primary SjÖgren's Syndrome: Detailed Analysis of 6 New Cases and 15 Cases from the Literature. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
80
|
Quartuccio L, Corazza L, Ramos-Casals M, Retamozo S, Ragab G, Ferraccioli G, Gremese E, Tzioufas A, Voulgarelis M, Vassilopoulos D, Koutsianas C, Scarpato S, Salvarani C, Guillevin L, Terrier B, Cacoub P, Saccardo F, Gabrielli A, Fraticelli P, Tomsic M, Tavoni A, Nishimoto N, Filippini D, Scaini P, Zignego A, Ferri C, Sansonno D, Monti G, Pietrogrande M, Galli M, Bombardieri S, De Vita S. OP0274 Cryoglobulinemic Vasculitis and Primary sjögren's Syndrome are Independent Risk Factors for Lymphoma in a Large Worldwide Population of Patients with Positive Serum Cryoglobulins. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
81
|
Guillevin L, Bussel A, Schooneman F, Amoura Z. Viscosity as the symptom leading to plasma exchange. CURRENT STUDIES IN HEMATOLOGY AND BLOOD TRANSFUSION 2015:220-38. [PMID: 2272203 DOI: 10.1159/000418562] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
82
|
Benarous L, Terrier B, Puéchal X, Dunogué B, Cohen P, Le Jeunne C, Mouthon L, Guillevin L. Tobacco differentially affects the clinical-biological phenotypes of ANCA-associated vasculitides. Clin Exp Rheumatol 2015; 33:S-116-21. [PMID: 26016761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2015] [Accepted: 04/17/2015] [Indexed: 06/04/2023]
Abstract
OBJECTIVES To describe the clinical-biological phenotype of ANCA-associated vasculitides (AAV) according to tobacco consumption. METHODS We conducted a descriptive study to describe that phenotype at diagnosis according to tobacco use. AAV patients entered in the French Vasculitis Study Group database with data on smoking habits were analysed. The clinical-biological phenotypes at diagnosis were compared according to current tobacco use (current smokers) or not (including previous and never smokers). RESULTS AAV diagnoses were: granulomatosis with polyangiitis (GPA) for 583 (50%), eosinophilic granulomatosis with polyangiitis (EGPA) for 326 (28%) and microscopic polyangiitis (MPA) for 256 (22%). Among them, 973 patients (84%) never smoked, 116 (10%) were previous smokers and only 76 (6%) were current smokers. Current smokers were younger age (p=0.01), male gender (p=0.004), less frequently EGPA (p=0.017) and MPA (p=0.036), and had less frequent kidney involvement (p=0.10). Among GPA patients, current smokers, compared to non-current smokers, were younger age (p=0.02), male gender (p=0.08), more frequent skin involvement (p=0.03) and less frequent ENT involvement (p=0.06). Among EGPA patients, current smokers, compared to non-current smokers, were also younger (p=0.028) and had less frequent constitutional symptoms (p=0.02), arthralgias (p=0.04), renal involvement (p=0.025) and MPO-ANCA (p=0.02). Finally, analysis of MPA patients was impossible because only 6 (2%) were current smokers. CONCLUSIONS These results suggest that tobacco use could differentially affect GPA and EGPA clinical-biological phenotypes, and support the role of environmental exposures in AAV development and its phenotype.
Collapse
|
83
|
Mohammad AJ, Hot A, Arndt F, Moosig F, Guerry MJ, Amudala N, Smith R, Sivasothy P, Guillevin L, Merkel PA, Jayne DRW. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss). Ann Rheum Dis 2014; 75:396-401. [DOI: 10.1136/annrheumdis-2014-206095] [Citation(s) in RCA: 144] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2014] [Accepted: 11/15/2014] [Indexed: 12/19/2022]
|
84
|
De Parisot A, Raverot G, Langrand C, Gil H, Vinzio S, Berthier S, Le G, Perard L, Ninet J, Cordier J, Guillevin L, Sève P. Atteinte hypothalamohypophysaire au cours de la granulomatose avec polyangéite : analyse rétrospective de six cas et revue de la littérature. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
85
|
Regent A, Ly K, Groh M, Khifer C, Clary G, Broussard C, Federici C, Baud V, Le Jeunne C, Witko-Sarsat V, Guillevin L, Mouthon L. Analyse protéomique et génomique des cellules musculaires lisses vasculaires au cours de l’artérite à cellules géantes (maladie de Horton). Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
86
|
De Luna G, Karras A, Jourde-Chiche N, Marchand-Adam S, Bally S, Aumaître O, Puéchal X, Le Jeunne C, Mouthon L, Guillevin L, Terrier B. Utilisation des échanges plasmatiques au cours de vascularites nécrosantes systémiques. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
87
|
Samson M, Puéchal X, Devilliers H, Cohen P, Bienvenu B, Ly K, Ruivard M, Hamidou M, Terrier B, Pagnoux C, Mouthon L, Guillevin L. Périartérite noueuse et polyangéite microscopique avec facteur de mauvais pronostic : suivi au long cours de 65 patients inclus dans un essai prospectif. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
88
|
Dunogué B, Briot K, Régent A, Cohen P, Berezne A, Puéchal X, Le Jeunne C, Roux C, Mouthon L, Guillevin L, Terrier B. Prévalence élevée de l’ostéoporose et des fractures chez les patients ayant une vascularite primitive nécrosante. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
89
|
Guillevin L. Vascularites associées aux anticorps anticytoplasme des polynucléaires neutrophiles : nouveaux traitements. MEDECINE INTENSIVE REANIMATION 2014. [DOI: 10.1007/s13546-014-0932-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
90
|
De Luna G, Terrier B, Kaminsky P, Le Quellec A, Maurier F, Solans R, Godmer P, Costedoat-Chalumeau N, Seror R, Charles P, Cohen P, Puechal X, Mouthon L, Guillevin L. Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes. Rheumatology (Oxford) 2014; 54:424-32. [DOI: 10.1093/rheumatology/keu336] [Citation(s) in RCA: 68] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
91
|
Chaigne B, Gatault P, Darrouzain F, Barbet C, Degenne D, François M, Szymanski P, Rabot N, Golea G, Diot E, Maillot F, Lebranchu Y, Nivet H, Paintaud G, Halimi JM, Guillevin L, Büchler M. Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study. Clin Exp Immunol 2014; 176:172-9. [PMID: 24304103 DOI: 10.1111/cei.12246] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/29/2013] [Indexed: 12/13/2022] Open
Abstract
Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) treatment strategy is based on immunosuppressive agents. Little information is available concerning mycophenolic acid (MPA) and the area under the curve (AUC) in patients treated for AAV. We evaluated the variations in pharmacokinetics for MPA in patients with AAV and the relationship between MPA-AUC and markers of the disease. MPA blood concentrations were measured through the enzyme-multiplied immunotechnique (C(0), C(30), C(1), C(2), C(3), C(4), C(6) and C(9)) to determine the AUC. Eighteen patients were included in the study. The median (range) MPA AUC(0-12) was 50·55 (30·9-105·4) mg/h/l. The highest coefficient of determination between MPA AUC and single concentrations was observed with C(3) (P < 0·0001) and C(2) (P < 0·0001) and with C(4) (P < 0·0005) or C(0) (P < 0·001). Using linear regression, the best estimation of MPA AUC was provided by a model including C(30), C(2) and C(4): AUC = 8·5 + 0·77 C(30) + 4·0 C(2) + 1·7 C(4) (P < 0·0001). Moreover, there was a significant relationship between MPA AUC(0-12) and lymphocyte count (P < 0·01), especially CD19 (P < 0·005), CD8 (P < 0·05) and CD56 (P < 0·05). Our results confirm the interindividual variability of MPA AUC in patients treated with MMF in AAV and support a personalized therapy according to blood levels of MPA.
Collapse
|
92
|
Mekinian A, Mirault T, Lambert M, Sibilia J, Hie M, Comarmond C, Messas E, Berthier S, Neel A, Hamidou M, Cohen P, Marie I, Lavigne C, Amoura Z, Guillevin L, Godeau B, Fain O, Cacoub P, Saadoun D. AB0568 Biologics in Takayasu Arteritis: Preliminary Data from the French Registry. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.5308] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
93
|
Philipson R, Anderson J, Brown J, Busse W, Cid M, Gleich G, Gross W, Guillevin L, Ortega H, Jayne D, Pagnoux C, Savage C, Weller P, Wechsler M. AB0578 Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangitis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
94
|
Dunogué B, Cohen P, Terrier B, Marmursztejn J, Duboc D, Vignaux O, Guillevin L. Interprétation diagnostique et pronostique des anomalies cardiaques détectées par imagerie par résonance magnétique au cours de la granulomatose éosinophilique avec polyangéite. Une étude rétrospective de 42 observations. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
95
|
Calich AL, Puéchal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L. Efficacité et sécurité du rituximab en traitement d’induction et d’entretien de la granulomatose avec polyangéite. Résultats d’une cohorte monocentrique de 66 patients. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
96
|
Lazzaroni M, Fredi M, Andreoli L, Brucato A, Caporali R, Caramaschi P, Doria A, Gerosa M, Guillevin L, Inverardi F, Lojacono A, Meroni P, Montecucco C, Mosca M, Motta M, Ramoni V, Sfriso P, Sinico R, Strigini F, Tani C, Tincani A. OP0230 Systemic Vasculitis and Pregnancy: A Multicenter Study on Maternal and Neonatal Outcome of 66 Prospectively Followed Pregnancies. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
97
|
Dunogué B, Gerin M, Larroche C, Montagnier-Petrissans C, Guillevin L, Mouthon L. Les immunoglobulines intraveineuses dans le traitement du syndrome d’activation macrophagique secondaire. Une étude rétrospective de 46 patients. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
98
|
Audemard A, Pillebout E, Le Gouellec N, Jourde-Chiche N, Goutte J, Maurier F, Sanges S, Cacoub P, Mouthon L, Guillevin L, Thervet E, Terrier B. Caractéristiques clinco-biologiques et histologiques de l’atteinte rénale au cours des vascularites à IgA de l’adulte : étude rétrospective de 104 patients. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
99
|
Pugnet G, Pagnoux C, Karras A, Aumaitre O, Cohen P, Mahr A, Terrier B, Ravaud P, Mouthon L, Guillevin L. Traitement d’entretien des vascularites associées aux ANCA, comparant le rituximab à l’azathioprine (MAINRITSAN) : impact sur la qualité de vie, 24 mois après l’inclusion. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
100
|
Benarous L, Terrier B, Berezne A, Dunogué B, Laborde-Casterot H, Cohen P, Puéchal X, Costedoat-Chalumeau N, Le Jeunne C, Choudat D, Mouthon L, Guillevin L. Étude comparative de la qualité de vie chez les patients atteints de vascularites associées aux ANCA. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|